Small-Molecule Inhibition of Rho/MKL/SRF Transcription in Prostate Cancer Cells: Modulation of Cell Cycle, ER Stress, and Metastasis Gene Networks

Overview

Journal Microarrays (Basel)

Date 2016 Sep 8

PMID 27600078

Citations 15

Authors

Chris R Evelyn

Erika M Lisabeth

Susan M Wade

Andrew J Haak

Craig N Johnson

Elizabeth R Lawlor

Richard R Neubig

Affiliations

Soon will be listed here.

Abstract

Metastasis is the major cause of cancer deaths and control of gene transcription has emerged as a critical contributing factor. RhoA- and RhoC-induced gene transcription via the actin-regulated transcriptional co-activator megakaryocytic leukemia (MKL) and serum response factor (SRF) drive metastasis in breast cancer and melanoma. We recently identified a compound, CCG-1423, which blocks Rho/MKL/SRF-mediated transcription and inhibits PC-3 prostate cancer cell invasion. Here, we undertook a genome-wide expression study in PC-3 cells to explore the mechanism and function of this compound. There was significant overlap in the genes modulated by CCG-1423 and Latrunculin B (Lat B), which blocks the Rho/MKL/SRF pathway by preventing actin polymerization. In contrast, the general transcription inhibitor 5,6-dichloro-1-β-d-ribofuranosyl-1H-benzimidazole (DRB) showed a markedly different pattern. Effects of CCG-1423 and Lat B on gene expression correlated with literature studies of MKL knock-down. Gene sets involved in DNA synthesis and repair, G1/S transition, and apoptosis were modulated by CCG-1423. It also upregulated genes involved in endoplasmic reticulum stress. Targets of the known Rho target transcription factor family E2F and genes related to melanoma progression and metastasis were strongly suppressed by CCG-1423. These results confirm the ability of our compound to inhibit expression of numerous Rho/MKL-dependent genes and show effects on stress pathways as well. This suggests a novel approach to targeting aggressive cancers and metastasis.

Citing Articles

Pirin does not bind to p65 or regulate NFκB-dependent gene expression but does modulate cellular quercetin levels.

Meschkewitz M, Lisabeth E, Cab-Gomez A, Leipprandt J, Neubig R bioRxiv. 2024; .

PMID: 39677728 PMC: 11642861. DOI: 10.1101/2024.12.03.626411.

Transcriptional profiling of rare acantholytic disorders suggests common mechanisms of pathogenesis.

Roth-Carter Q, Burks H, Ren Z, Koetsier J, Tsoi L, Harms P JCI Insight. 2023; 8(16).

PMID: 37471166 PMC: 10543711. DOI: 10.1172/jci.insight.168955.

SRF inhibitors reduce prostate cancer cell proliferation through cell cycle arrest in an isogenic model of castrate-resistant prostate cancer.

Azam H, Maher S, Clarke S, Gallagher W, Prencipe M Cell Cycle. 2023; 22(14-16):1759-1776.

PMID: 37377210 PMC: 10446773. DOI: 10.1080/15384101.2023.2229713.

The endoplasmic reticulum stress response in prostate cancer.

de la Calle C, Shee K, Yang H, Lonergan P, Nguyen H Nat Rev Urol. 2022; 19(12):708-726.

PMID: 36168057 DOI: 10.1038/s41585-022-00649-3.

'Cloudbuster': a Python-based open source application for three-dimensional reconstruction and quantification of stacked biological imaging samples.

Rohwedder A, Knipp S, Esteves F, Hale M, Ketchen S, Treanor D Interface Focus. 2022; 12(5):20220016.

PMID: 35996739 PMC: 9372645. DOI: 10.1098/rsfs.2022.0016.

References

Mundy G . Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002; 2(8):584-93. DOI: 10.1038/nrc867. View

Lu B, Fang Y, Xu J, Wang L, Xu F, Xu E . Analysis of SOX9 expression in colorectal cancer. Am J Clin Pathol. 2008; 130(6):897-904. DOI: 10.1309/AJCPW1W8GJBQGCNI. View

Hakem A, Sanchez-Sweatman O, You-Ten A, Duncan G, Wakeham A, Khokha R . RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev. 2005; 19(17):1974-9. PMC: 1199568. DOI: 10.1101/gad.1310805. View

Clark E, Golub T, Lander E, Hynes R . Genomic analysis of metastasis reveals an essential role for RhoC. Nature. 2000; 406(6795):532-5. DOI: 10.1038/35020106. View

Evelyn C, Wade S, Wang Q, Wu M, Iniguez-Lluhi J, Merajver S . CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling. Mol Cancer Ther. 2007; 6(8):2249-60. DOI: 10.1158/1535-7163.MCT-06-0782. View

Kauffmann A, Rosselli F, Lazar V, Winnepenninckx V, Mansuet-Lupo A, Dessen P . High expression of DNA repair pathways is associated with metastasis in melanoma patients. Oncogene. 2007; 27(5):565-73. DOI: 10.1038/sj.onc.1210700. View

Yang J, Weinberg R . Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008; 14(6):818-29. DOI: 10.1016/j.devcel.2008.05.009. View

Cen B, Selvaraj A, Burgess R, Hitzler J, Ma Z, Morris S . Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes. Mol Cell Biol. 2003; 23(18):6597-608. PMC: 193697. DOI: 10.1128/MCB.23.18.6597-6608.2003. View

Sawyer T . Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors. Expert Opin Investig Drugs. 2003; 13(1):1-19. DOI: 10.1517/13543784.13.1.1. View

10.

Hurst J, Mendpara N, Hooks S . Regulator of G-protein signalling expression and function in ovarian cancer cell lines. Cell Mol Biol Lett. 2008; 14(1):153-74. PMC: 6275869. DOI: 10.2478/s11658-008-0040-7. View

11.

Miralles F, Posern G, Zaromytidou A, Treisman R . Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell. 2003; 113(3):329-42. DOI: 10.1016/s0092-8674(03)00278-2. View

12.

Kang Y, Siegel P, Shu W, Drobnjak M, Kakonen S, Cordon-Cardo C . A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003; 3(6):537-49. DOI: 10.1016/s1535-6108(03)00132-6. View

13.

Chen H, Tsai S, Leone G . Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer. 2009; 9(11):785-97. PMC: 3616489. DOI: 10.1038/nrc2696. View

14.

Liu L, Li Z, Feng G, You W, Li J . Expression of connective tissue growth factor is in agreement with the expression of VEGF, VEGF-C, -D and associated with shorter survival in gastric cancer. Pathol Int. 2007; 57(11):712-8. DOI: 10.1111/j.1440-1827.2007.02162.x. View

15.

Wang X, Adams L, Pabon L, Mahoney Jr W, Beaudry D, Gunaje J . RGS5, RGS4, and RGS2 expression and aortic contractibility are dynamically co-regulated during aortic banding-induced hypertrophy. J Mol Cell Cardiol. 2008; 44(3):539-50. DOI: 10.1016/j.yjmcc.2007.11.019. View

16.

Ram P, Horvath C, Iyengar R . Stat3-mediated transformation of NIH-3T3 cells by the constitutively active Q205L Galphao protein. Science. 1999; 287(5450):142-4. DOI: 10.1126/science.287.5450.142. View

17.

Li M, Sanchez T, Pappalardo A, Lynch K, Hla T, Ferrer F . Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2. Mol Cancer Res. 2008; 6(10):1649-56. PMC: 2659653. DOI: 10.1158/1541-7786.MCR-07-2048. View

18.

Sequeira L, Dubyk C, Riesenberger T, Cooper C, van Golen K . Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis. Clin Exp Metastasis. 2008; 25(5):569-79. DOI: 10.1007/s10585-008-9173-3. View

19.

Narumiya S, Tanji M, Ishizaki T . Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev. 2009; 28(1-2):65-76. DOI: 10.1007/s10555-008-9170-7. View

20.

Gupta G, Massague J . Cancer metastasis: building a framework. Cell. 2006; 127(4):679-95. DOI: 10.1016/j.cell.2006.11.001. View